92 related articles for article (PubMed ID: 299242)
21. [Clinical study of the epidermal growth factor contents in urine, plasma and tissue from the patients with urological diseases].
Miyazaki S
Hinyokika Kiyo; 1992 Aug; 38(8):919-24. PubMed ID: 1414740
[TBL] [Abstract][Full Text] [Related]
22. [Diagnosis of malignancy in the urinary tract and prostate gland from the aspect of hematuria].
Kitamura T; Murahashi I; Kawabe K; Aso Y
Nihon Jinzo Gakkai Shi; 1990 Jan; 32(1):71-5. PubMed ID: 2348576
[TBL] [Abstract][Full Text] [Related]
23. On the origin of lactic dehydrogenase isoenzymes in urine.
Dubach UC
Helv Med Acta; 1966 Jun; 33(2):139-50. PubMed ID: 4164323
[No Abstract] [Full Text] [Related]
24. Evaluation of nuclear matrix protein-22 as a clinical diagnostic marker for bladder cancer.
Chang YH; Wu CH; Lee YL; Huang PH; Kao YL; Shiau MY
Urology; 2004 Oct; 64(4):687-92. PubMed ID: 15491702
[TBL] [Abstract][Full Text] [Related]
25. [Value of carcinoembryonic antigen (CEA) in the diagnosis of malignant tumors of the urogenital tract].
Rost A; Kneppenberg U; Rost P
Helv Chir Acta; 1976 Jul; 43(3):271-8. PubMed ID: 947865
[TBL] [Abstract][Full Text] [Related]
26. [Microscopic hematuria in adults--a diagnostic dilemma. Scientific guidelines for management are not available according to a review of the literature].
Köhler C; Varenhorst E
Lakartidningen; 1999 Nov; 96(45):4911-6. PubMed ID: 10596530
[TBL] [Abstract][Full Text] [Related]
27. Impact of prostate-specific antigen level and prostate volume as predictors of efficacy in photoselective vaporization prostatectomy: analysis and results of an ongoing prospective multicentre study at 3 years.
Te AE; Malloy TR; Stein BS; Ulchaker JC; Nseyo UO; Hai MA
BJU Int; 2006 Jun; 97(6):1229-33. PubMed ID: 16686717
[TBL] [Abstract][Full Text] [Related]
28. [Detection of urological and male genital tumors diagnosed in Beijing Hospital 1995 - 2004].
Liu M; Wang JY; Zhang YG; Zhu SC; Lu ZH; Wan B
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2423-5. PubMed ID: 18036323
[TBL] [Abstract][Full Text] [Related]
29. NTP Toxicology and Carcinogenesis Studies of Tetrafluoroethylene (CAS No. 116-14-3) in F344 Rats and B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 Apr; 450():1-321. PubMed ID: 12594525
[TBL] [Abstract][Full Text] [Related]
30. Bladder tumor antigen stat test in non-urothelial malignant urologic conditions.
Wald M; Halachmi S; Amiel G; Madjar S; Mullerad M; Miselevitz I; Moskovitz B; Nativ O
Isr Med Assoc J; 2002 Mar; 4(3):174-5. PubMed ID: 11908255
[TBL] [Abstract][Full Text] [Related]
31. [The excretion of N-acetyl-beta-D-glucosaminidase in the urine of children with urinary tract diseases].
Zandvliet EE; Giesberts MA; van Gelderen HH
Tijdschr Kindergeneeskd; 1983 Aug; 51(4):135-8. PubMed ID: 6670088
[TBL] [Abstract][Full Text] [Related]
32. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
[TBL] [Abstract][Full Text] [Related]
33. Urinary tissue factor levels in patients with bladder and prostate cancer.
Lwaleed BA; Francis JL; Chisholm M
Eur J Surg Oncol; 2000 Feb; 26(1):44-9. PubMed ID: 10718179
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of two new urinary tumor markers: bladder tumor fibronectin and cytokeratin 18 for the diagnosis of bladder cancer.
Sánchez-Carbayo M; Urrutia M; González de Buitrago JM; Navajo JA
Clin Cancer Res; 2000 Sep; 6(9):3585-94. PubMed ID: 10999749
[TBL] [Abstract][Full Text] [Related]
35. [Cytology of the urinary tract. A demonstration of indications and cytologic findings in various disease pictures].
Fladerer HP
Fortschr Med; 1984 Sep; 102(33):815-8. PubMed ID: 6479823
[TBL] [Abstract][Full Text] [Related]
36. [Current trends in the treatment of urological patients with transplanted kidney].
Trapeznikova MF; Urenkov SB; Zubrilina NM; Podoĭnitsyn AA
Urologiia; 2009; (2):9-13. PubMed ID: 19526868
[TBL] [Abstract][Full Text] [Related]
37. NTP Toxicology and Carcinogenesis Studies of 1,3-Butadiene (CAS No. 106-99-0) in B6C3F1 Mice (Inhalation Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 May; 434():1-389. PubMed ID: 12616297
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic value of macroscopic haematuria for the diagnosis of urological cancer in general practice.
Bruyninckx R; Buntinx F; Aertgeerts B; Van Casteren V
Br J Gen Pract; 2003 Jan; 53(486):31-5. PubMed ID: 12564274
[TBL] [Abstract][Full Text] [Related]
39. [Serum and urinary tissue polypeptide antigen (TPA) in patients with urological cancer].
Kazama T; Katayama T; Yamazaki N
Hinyokika Kiyo; 1985 Dec; 31(12):2113-9. PubMed ID: 3832915
[TBL] [Abstract][Full Text] [Related]
40. Differences in Urinary Amino Acid Patterns in Individuals with Different Types of Urological Tumor Urinary Amino Acid Patterns as Markers of Urological Tumors.
Duskova K; Vesely S; DO Carmo Silva J; Cernei N; Zitka O; Heger Z; Adam V; Havlova K; Babjuk M
In Vivo; 2018; 32(2):425-429. PubMed ID: 29475932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
